# Otsuka Pharmaceutical Co., Ltd., Naka-Gun, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/otsuka-pharmaceutical-co-ltd/4106c23b-a243-4485-8ab6-a3dd8a7258ad

> Inspection records and compliance data for Otsuka Pharmaceutical Co., Ltd. in Naka-Gun. 5 FDA inspections on record, 1 Form 483, last inspected June 17, 2025.

---

## Details

- Name: Otsuka Pharmaceutical Co., Ltd.
- FEI Number: 3004810250
- Address Line 1: Azaotsubo 2, Koniu; Naka-Cho
- City: Naka-Gun
- Country Name: Japan
- Address: Azaotsubo 2, Koniu; Naka-Cho, Naka-Gun, Japan
- Country: Japan

## Related Documents

- [483 - Otsuka Pharmaceutical Co., Ltd. - 2025-06-17](https://www.keypedia.com/records/483/otsuka-pharmaceutical-co-ltd/500e2ebb-23c6-432a-a86f-6865269ae086) — source: FDA, date: June 17, 2025
- [FDA Inspection 1265342 - Otsuka Pharmaceutical Co., Ltd. - 2025-06-17](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-co-ltd/cd62a295-51a7-49ae-b140-a2c0ef894119) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 17, 2025
- [483 - Otsuka Pharmaceutical Co., Ltd. - 2019-10-22](https://www.keypedia.com/records/483/otsuka-pharmaceutical-co-ltd/d3b34d94-f15f-409d-b27b-8a21017a34f0) — source: FDA, date: October 22, 2019
- [FDA Inspection 1107691 - Otsuka Pharmaceutical Co., Ltd. - 2019-10-22](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-co-ltd/f30fa95f-343e-421f-b13a-4b04ac8cc11a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2019
- FDA Inspection 994655 - Otsuka Pharmaceutical Co., Ltd. - 2016-09-22 — classification: No Action Indicated (NAI), source: FDA, date: September 22, 2016
- FDA Inspection 994655 - Otsuka Pharmaceutical Co., Ltd. - 2016-09-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2016
- [FDA Inspection 887144 - Otsuka Pharmaceutical Co., Ltd. - 2014-06-17](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-co-ltd/c4dc4524-e56e-4104-89e2-d0de9ff9cda4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 17, 2014
- FDA Inspection 793343 - Otsuka Pharmaceutical Co., Ltd. - 2012-07-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2012

## Related Companies

- [Kelix bio (Malta) Ltd.](https://www.keypedia.com/companies/kelix-bio-malta-ltd/3595e81b-9a31-4dcc-b529-e58034aabdf7)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/f6a46248-6051-4cd6-8fa4-220f0a33652c)
- [Caplin Steriles Limited](https://www.keypedia.com/companies/caplin-steriles-limited/af5b53d8-1adc-41f4-ab8d-0149b3b5b9cb)
- [HP Halden Pharma AS](https://www.keypedia.com/companies/hp-halden-pharma-as/2c8c6d51-da3a-476a-9abd-da411b527728)
- [Digestive Care Inc](https://www.keypedia.com/companies/digestive-care-inc/c4de8703-81c2-4afc-9e51-392b626b8e63)
- [Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.)](https://www.keypedia.com/companies/bora-pharmaceuticals-frmly-twi-pharmaceuticals-inc/103fb1af-ac77-4f76-9476-8430e4586638)
- [Aizant Drug Research Solutions Private Ltd.](https://www.keypedia.com/companies/aizant-drug-research-solutions-private-ltd/1a2d8dae-2eb4-4bc8-b36b-e94775bccd50)
- [Novel Laboratories, Inc. d.b.a Lupin Somerset](https://www.keypedia.com/companies/novel-laboratories-inc-dba-lupin-somerset/53a42119-c077-49fb-b739-db29c2b99391)
- [Cerovene Inc.](https://www.keypedia.com/companies/cerovene-inc/f23e944b-ef46-45b3-8177-af154b404c08)
- [UBI Pharma, Inc.](https://www.keypedia.com/companies/ubi-pharma-inc/c7dfbd38-5fae-4a48-b959-a3abae44f320)

## Related Officers

- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)
